Short blood thinners after stenting for stable angina
Part of Heart & circulation, Pain clinical trials.
This trial is testing a way to shorten the time you need to take blood thinners after getting a specific type of heart stent. It uses a special camera (OCT) inside the artery to help decide if stents are placed well enough to allow less time on dual antiplatelet therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are having a coronary stent placed (a cobalt-chromium everolimus-eluting stent) for stable angina (chest pain that comes on with activity and goes away with rest).
- You must be at least 19 years old and willing to follow the study schedule and give written permission (informed consent).
- You cannot have had a recent heart attack or unstable angina (sudden chest pain that feels new or worse).
- You cannot have any medical reason that prevents you from taking blood thinners or having a special camera test called OCT (optical coherence tomography).
- The artery being treated must not be too severely blocked, heavily calcified (hardened), or too twisted for the doctor to safely place the stent.
- You cannot already have a stent in the same spot that is being treated.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether choosing blood thinners based on each person's needs works better than a standard approach after getting a heart stent. It aims to reduce risks like blood clots or bleeding.
This trial tests an algorithm (computer-guided plan) to choose the best “dual antiplatelet therapy” (two blood-thinning medicines) after a coronary stent. It aims to improve outcomes after the procedure while reducing avoidable problems from the medicines.
This study tests whether taking a single blood-thinning medication (instead of two) after heart stent placement is safe and effective over the long term. If you've recovered well from a stent procedure, this trial may help determine the safest way to prevent future heart problems.
This trial studies ways to reduce bleeding in people after a stent procedure (PCI) who have been taking two anti-platelet medicines (aspirin plus prasugrel or ticagrelor) for a set amount of time. It may help find a safer plan for preventing blood clots while lowering bleeding risk.
This Phase 4 study tests a way to measure blood flow in heart arteries to help doctors choose the best stent plan. It may help improve safety and effectiveness for people having elective heart stent procedures for stable angina or certain heart attacks.
This trial is testing whether lowering the dose of your current blood thinner or switching to a different one (clopidogrel) is safer and works just as well after you've had a stent placed. It's designed for people who are already on two blood thinners and are doing well.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.